Labcorp Holdings Inc. (LH)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Labcorp Holdings Inc..
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 7 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 309.20 $ — 91% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 7.5% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 20
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 18.36 | 18.15 – 18.48 | 14,746 | 11.7% | 15 |
| 12/31/2027 | 19.75 | 18.73 – 20.43 | 15,456 | 7.6% | 18 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 1.70 | – | 3,329 | 9.80 | 4.30 | 777 | 665 |
| 2025: Q1 | 2.52 | -6.20 | 3,345 | 5.30 | 6.40 | 19 | -108 |
| 2025: Q2 | 2.83 | 16.20 | 3,527 | 9.50 | 6.70 | 621 | 543 |
| 2025: Q3 | 3.12 | 55.50 | 3,564 | 8.60 | 7.30 | 387 | 281 |
| 2025: Q4 | 1.98 | 16.20 | 3,516 | 5.60 | 4.70 | 614 | 490 |
| 2026: Q1 | 3.35 | 32.70 | 3,538 | 5.80 | 7.90 | 192 | 71 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 9,642 | 1,312 | 732 | 7.02 | 1,176 | 5,506 | 14,247 |
| 2017 | 10,441 | 1,364 | 1,268 | 12.21 | 1,459 | 6,804 | 16,568 |
| 2018 | 11,333 | 1,326 | 884 | 8.61 | 1,305 | 6,971 | 16,185 |
| 2019 | 11,555 | 1,330 | 824 | 8.36 | 1,445 | 7,567 | 18,021 |
| 2020 | 13,979 | 2,445 | 1,556 | 15.88 | 2,135 | 9,437 | 20,072 |
| 2021 | 13,136 | 3,049 | 2,377 | 24.38 | 3,110 | 10,273 | 20,385 |
| 2022 | 11,864 | 1,437 | 1,279 | 13.96 | 1,956 | 10,097 | 20,155 |
| 2023 | 12,162 | 726 | 418 | 4.77 | 1,328 | 7,875 | 16,725 |
| 2024 | 13,009 | 1,087 | 746 | 8.84 | 1,586 | 8,052 | 18,379 |
| 2025 | 13,952 | 1,516 | 877 | 10.46 | 1,641 | 8,620 | 18,393 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Labcorp Holdings Inc. bietet Labordienste an.
| CEO Insider Trades (12 Mo.) | selling own stock |
|---|---|
| Employees | 71,000 |
| Headquarters | Burlington, NC |
| Address | 358 South Main Street, 27215 Burlington, United States |
| Phone | 336 229 1127 |
| Website | labcorp.com |
| IPO Date | 29. Mar 1990 |
| ISIN | US5049221055 |
| Stock Split | 1164:1000 on 07/03/2023 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Adam H. Schechter | President, CEO & Chairman | 1965 |
| Julia A. Wang | CFO & Executive VP | 1972 |
| Brian J. Caveney J.D., M.D., M.P.H. | EVP, President of Early Development Research Laboratories and Chief Medical & Scientific Officer | 1974 |
| Megan D. Bailey M.P.H. | Executive VP and President of Central Laboratory Services & International Labcorp | 1980 |
| Jonathan C. Meltzer Ph.D. | EVP & Chief Operations Officer | – |
| Peter J. Wilkinson | Senior VP & Chief Accounting Officer | 1971 |
| Akinbolade Oyegunwa M.B.A., Ph.D. | Executive VP and Chief Information & Technology Officer | 1983 |
| Kathryn Wright Kyle | Executive VP, Chief Legal Officer and Corporate Secretary | 1971 |
| Amy B. Summy | EVP, Chief Marketing Officer & Consumer Health Lead | 1966 |
| Anita Z. Graham | Executive VP & Chief Human Resources Officer | 1971 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.